| 货号 | 19645-5mg |
| 描述 | Bepridil is a dihydropyridine that has anti-anginal and anti-arrhythmic actions by blocking calcium channels in heart and smooth muscle.1,2 It is recognized as a non-selective channel blocker, altering myocardial Ca2+, Na+, and K+currents.3 For example, it blocks voltage-gated Ca2+(Cav3.2) and K+ (hERG and KCNQ4) channels, sarcoplasmic ATP-sensitive K+(KATP) channels, and Na+-activated (KNa) channels (IC50s = 7.1, 22, 9.4, 10, and 2.2 µM, respectively).4,5,6,2 It also activates mitochondrial ATP-sensitive KATP channels (ED50 = 27.5 µM).7 |
| 供应商 | Cayman |
| 应用文献 | |
| 1.Singh, B.N. The mechanism of action of calcium antagonists relative to their clinical applications. Br. J. Clin. Pharmacol. 21, 109S-121S (1986). 2.Perez-Reyes, E.,Van Deusen, A.L., and Vitko, I. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: Block by antihypertensives, antiarrhythmics, and their analogs. Journal of Pharmacology and Experimental Therapeutics 328(2), 621-627 (2009). 3.Iijima, K.,Chinushi, M.,Izumi, D., et al. Effect of bepridil in atrial fibrillation inducibility facilitated by vagal nerve stimulation. Prevention of vagal nerve activation-induced shortening of the atrial action potential duration. Circulation Journal 74(5), 895-902 (2010). 4.Sinha, N., and Sen, S. Predicting hERG activities of compounds from their 3D structures: Development and evaluation of a global descriptors based QSAR model. European Journal of Medicinal Chemistry 46(2), 618-630 (2011). 5.Sogaard, R.,Ljungstrom, T.,Pedersen, K.A., et al. KCNQ4 channels expressed in mammalian cells: Functional characteristics and pharmacology. American Journal of Physiology.Cell Physiology 280(4), C859-C866 (2001). 6.Li, Y.,Sato, T., and Arita, M. Bepridil blunts the shortening of action potential duration caused by metabolic inhibition via blockade of ATP-sensitive K+ channels and Na+-activated K+ channels. Journal of Pharmacology and Experimental Therapeutics 291(2), 562-568 (1999). 7.Sato, T.,Costa, A.D.T.,Saito, T., et al. Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection. Journal of Pharmacology and Experimental Therapeutics 316(1), 182-188 (2006). | |
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 403 |
| 分子式 | C24H34N2O • HCl |
| CAS号 | 68099-86-5 |
| 稳定性 | ≥ 2 years |
| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |